|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02563 BIOSTAR PHARM-B
Nominal 
7.790 +0.070 (+0.907%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 163,724 | 33.424% | 122,710 | 102,902 |
| Land & other Lease Assets | 13,556 | 0.586% | 13,477 | 14,862 |
| Intangible Assets | 752 | -53.780% | 1,627 | 2,832 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 35,953 | 3495.300% | 1,000 | 1,072 |
| 213,985 | 54.152% | 138,814 | 121,668 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 31,419 | 15.227% | 27,267 | 31,109 | |
| Trade Receivables | 23,152 | 107.474% | 11,159 | 34,620 | |
| Cash & Bank Balances | 189,714 | 398.107% | 38,087 | 60,106 | |
| Other Current Assets | 454,973 | -18.320% | 557,017 | 678,835 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 699,258 | 10.375% | 633,530 | 804,670 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 48,331 | 97.754% | 24,440 | 20,099 | ||
| S-T Debt & Leases | 665 | -9.153% | 732 | 1,091 | ||
| Other Current Liabilities | 30,165 | 62.431% | 18,571 | 30,535 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 79,161 | 80.968% | 43,743 | 51,725 | |||
| Net Current Assets | 620,097 | 5.139% | 589,787 | 752,945 | ||
| Total Assets Less Current Liabilities | 834,082 | 14.477% | 728,601 | 874,613 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 517 | 209.581% | 167 | 813 | |||
| Other Non-current Liabilities | 42,819 | 712.042% | 5,273 | 5,875 | |||
| 43,336 | 696.618% | 5,440 | 6,688 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 364,588 | 4.168% | 350,000 | 350,000 | ||||
| Reserves | 426,158 | 14.202% | 373,161 | 517,925 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 790,746 | 9.346% | 723,161 | 867,925 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 790,746 | 9.346% | 723,161 | 867,925 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 108,402 | 136,242 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 23/07/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -143,776 |
| %Change | -24.186% |
| EPS / (LPS) | RMB -0.410 |
| NBV Per Share (¥) | RMB 2.169 |